Avior Wealth Management’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,487
Closed -$15.3K 2183
2024
Q4
$15.3K Buy
1,487
+1,274
+598% +$15.9K ﹤0.01% 1489
2024
Q3
$2.89K Buy
213
+6
+3% +$74 ﹤0.01% 1910
2024
Q2
$2.69K Buy
207
+39
+23% +$482 ﹤0.01% 1886
2024
Q1
$1.58K Buy
+168
New +$1.63K ﹤0.01% 2316

Other funds holding THRD

Avior Wealth Management's THRD Position: Q1 2025 in Review

Avior Wealth Management sold out of Third Harmonic Bio (THRD) in Q1 2025, closing a stake of 1,487 shares — an estimated $15.3K sold.

Avior Wealth Management first reported a position in THRD in Q1 2024 and held it in 4 quarters. The position peaked at $15.3K in Q4 2024. 99 funds tracked by Wall St. Rank hold THRD as of Q1 2025.

  • Avior Wealth Management reported no remaining Third Harmonic Bio position as of Q1 2025 after selling out during the quarter.
  • Avior Wealth Management sold 1,487 Third Harmonic Bio shares in Q1 2025, an estimated $15.3K.
  • Avior Wealth Management first reported a position in Third Harmonic Bio in Q1 2024 and held it in 4 quarters.
  • Avior Wealth Management's Third Harmonic Bio position peaked at $15.3K in Q4 2024.
  • 99 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q1 2025.

Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.